Renalytix (RNLX) said Thursday it has submitted a request for a hearing with Nasdaq to present a plan to regain compliance with the stock market's listing requirements.
The company said it has been notified that it has been out of compliance with Nasdaq minimum closing share price and market value requirements.
The hearing request automatically stays any suspension or delisting procedures, and the company's American Depositary Shares will continue trading on Nasdaq.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments